Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 58,057 | 60,300 | 55,206 | 49,305 | 49,761 |
| Cost of Goods | 52,597 | 53,862 | 48,370 | 43,300 | 43,500 |
| Gross Profit | 5,460 | 6,438 | 6,840 | 6,000 | 6,260 |
| Operating Expenses | 5,043 | 4,912 | 3,520 | 3,830 | 3,420 |
| Operating Income | 1,014 | 2,388 | 3,316 | 2,175 | 2,841 |
| Interest Expense | 1,263 | 1,203 | 920 | 890 | 850 |
| Other Income | 0 | 0 | 34 | -15 | -21 |
| Pre-tax Income | -249 | 1,185 | 2,430 | 1,270 | 1,970 |
| Income Tax | -76 | 420 | 1,010 | 460 | 730 |
| Net Income Continuous | -173 | 765 | 1,429 | 802 | 1,245 |
| Net Income | $-173 | $765 | $1,429 | $802 | $1,245 |
| EPS Basic Total Ops | -0.03 | 0.12 | 0.22 | 0.13 | 0.20 |
| EPS Basic Continuous Ops | -0.03 | 0.12 | 0.22 | 0.13 | 0.20 |
| EPS Diluted Total Ops | -0.03 | 0.12 | 0.22 | 0.13 | 0.20 |
| EPS Diluted Continuous Ops | -0.03 | 0.12 | 0.22 | 0.13 | 0.20 |
| EBITDA(a) | $2,020 | $3,441 | $4,136 | $3,025 | $3,701 |